These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25760076)

  • 1. The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.
    Wang R; Li Y; Hou Y; Yang Q; Chen S; Wang X; Wang Z; Yang Y; Chen C; Wang Z; Wu Q
    Oncotarget; 2015 Mar; 6(9):7000-10. PubMed ID: 25760076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway.
    Wu Q; Wang R; Yang Q; Hou X; Chen S; Hou Y; Chen C; Yang Y; Miele L; Sarkar FH; Chen Y; Wang Z
    Oncotarget; 2013 Nov; 4(11):1999-2009. PubMed ID: 24158561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.
    Liu Y; Li Y; Wang R; Qin S; Liu J; Su F; Yang Y; Zhao F; Wang Z; Wu Q
    J Exp Clin Cancer Res; 2016 Jan; 35():19. PubMed ID: 26817584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.
    Wu Q; Wang X; Liu J; Zheng J; Liu Y; Li Y; Su F; Ou W; Wang R
    Oncol Rep; 2016 Sep; 36(3):1325-32. PubMed ID: 27430152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1.
    Yin LC; Xiao G; Zhou R; Huang XP; Li NL; Tan CL; Xie FJ; Weng J; Liu LX
    Biomed Res Int; 2020; 2020():8891876. PubMed ID: 33381597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol inhibits proliferation, migration, and invasion of hepatocellular carcinoma cells by downregulating Twist.
    Zheng H; Fu Y; Yang T
    J Cell Biochem; 2019 Aug; 120(8):12803-12809. PubMed ID: 30861184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
    Ma J; Fang B; Zeng F; Ma C; Pang H; Cheng L; Shi Y; Wang H; Yin B; Xia J; Wang Z
    Oncotarget; 2015 Jan; 6(3):1740-9. PubMed ID: 25638153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
    Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
    Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
    Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis.
    Yang RM; Zhan M; Xu SW; Long MM; Yang LH; Chen W; Huang S; Liu Q; Zhou J; Zhu J; Wang J
    Cell Death Dis; 2017 Oct; 8(10):e3129. PubMed ID: 29048402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1.
    Feng M; Fang F; Fang T; Jiao H; You S; Wang X; Zhao W
    Lab Invest; 2020 Nov; 100(11):1400-1410. PubMed ID: 32461589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.